Safety and Efficacy of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration
NCT ID: NCT02462486
Last Updated: 2020-07-30
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
949 participants
INTERVENTIONAL
2015-06-25
2019-06-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
NCT02181517
A Study of Abicipar Pegol in Japanese Patients With Neovascular Age-related Macular Degeneration
NCT02181504
Safety and Pharmacokinetics of Abicipar Pegol Intravitreal Injections in Patients With Neovascular AMD
NCT02859766
A Safety and Efficacy Study of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration
NCT02462928
Evaluation of AGN-150998 in Exudative Age-related Macular Degeneration (AMD)
NCT01397409
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Abicipar Pegol 2 mg (2Q8)
Abicipar pegol 2 mg was administered to the study eye by intravitreal injection on Day 1, Week 4, and Week 8, followed by injections every 8 weeks through Week 96. Scheduled visits occurred every 4 weeks. To maintain masking, sham was administered to the study eye at scheduled visits where abicipar was not administered.
Abicipar Pegol
Abicipar pegol intravitreal injection.
Sham Procedure
Sham injection.
Abicipar Pegol 2 mg (2Q12)
Abicipar pegol 2 mg was administered to the study eye by intravitreal injection on Day 1, Week 4, and Week 12, followed by injections every 12 weeks through Week 96. Scheduled visits occurred every 4 weeks. To maintain masking, sham was administered to the study eye at scheduled visits where abicipar was not administered.
Abicipar Pegol
Abicipar pegol intravitreal injection.
Sham Procedure
Sham injection.
Ranibizumab (rQ4)
Ranibizumab (Lucentis®) was administered to the study eye by intravitreal injection every 4 weeks from Day 1 through Week 96.
Ranibizumab
Ranibizumab intravitreal injection.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Abicipar Pegol
Abicipar pegol intravitreal injection.
Ranibizumab
Ranibizumab intravitreal injection.
Sham Procedure
Sham injection.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Best corrected visual acuity of 20/40 to 20/320 in the study eye
* Best corrected visual acuity of 20/200 or better in the non-study eye
Exclusion Criteria
* Cataract or refractive surgery in the study eye within the last 3 months
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Allergan
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joanne Li
Role: STUDY_DIRECTOR
Allergan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Eye Foundation Hospital
Birmingham, Alabama, United States
Retinal Consultants of Arizona
Gilbert, Arizona, United States
Barnet Dulaney Perkins Eye Center - Phoenix
Phoenix, Arizona, United States
Retina Centers, PC
Tucson, Arizona, United States
Northwest Arkansas Retina Associates
Springdale, Arkansas, United States
Win Retina
Arcadia, California, United States
Retina Institute of California
Arcadia, California, United States
Retinal Diagnostic Center
Campbell, California, United States
Specialty Eye Care Medical Center, Inc.
Glendale, California, United States
University of California at Irvine Gavin Herbert Eye Institute
Irvine, California, United States
Retina Associates of Orange County
Laguna Hills, California, United States
South Coast Retina Center
Long Beach, California, United States
East Bay Retina Consultants, Inc.
Oakland, California, United States
San Diego Retina Associates
Oceanside, California, United States
Southern California Desert Retina Consultants
Palm Desert, California, United States
California Eye Specialist Medical Group
Pasadena, California, United States
Retina Consultants, San Diego
Poway, California, United States
Retina Consultants of Southern California
Redlands, California, United States
Kaiser Permanente Riverside Medical Center
Riverside, California, United States
UC Davis Medical Center, Department of Ophthalmology
Sacramento, California, United States
Retinal Consultants Medical Group, Inc.
Sacramento, California, United States
West Coast Retina Medical Group
San Francisco, California, United States
Pacific Eye Associates
San Francisco, California, United States
The Eye Associates
Bradenton, Florida, United States
National Ophthalmic Research Institute
Fort Myers, Florida, United States
Retina Macula Specialists of Miami
Miami, Florida, United States
MedEye Associates
Miami, Florida, United States
Fort Lauderdale Eye Institute
Plantation, Florida, United States
Sarasota Retina Institute
Sarasota, Florida, United States
East Florida Eye Institute
Stuart, Florida, United States
Retina Associate of Florida, P.A.
Tampa, Florida, United States
Retina Vitreous Associates of Florida
Tampa, Florida, United States
Center for Retina and Macular Disease
Winter Haven, Florida, United States
Southeast Retina Center
Augusta, Georgia, United States
Rush University Medical Center
Chicago, Illinois, United States
DuPage Medical Group
Downers Grove, Illinois, United States
Kovach Eye Institute
Elmhurst, Illinois, United States
University Retina and Macula Associates
Oak Forest, Illinois, United States
Wheaton Eye Clinic, Clinical Research Center, LLC
Wheaton, Illinois, United States
Sabates Eye Centers
Leawood, Kansas, United States
Paducah Retinal Center
Paducah, Kentucky, United States
The Retina Care Center
Baltimore, Maryland, United States
Cumberland Valley Retina Consultants, P.C.
Hagerstown, Maryland, United States
Vitreo-Retinal Associates, Pc
Worcester, Massachusetts, United States
Retina Specialists of Michigan
Grand Rapids, Michigan, United States
University of Mississippi Medical Center
Jackson, Mississippi, United States
Retina Center of New Jersey, LLC
Bloomfield, New Jersey, United States
Delaware Valley Retina Associates
Lawrenceville, New Jersey, United States
Long Island Vitreoretinal Consultants
Hauppauge, New York, United States
Maculacare - New York
New York, New York, United States
Retina Vitreous Surgeons of Central NY, PC
Syracuse, New York, United States
Western Carolina Retinal Associates, PA
Asheville, North Carolina, United States
Charlotte Eye Ear Nose & Throat Associates, PA
Charlotte, North Carolina, United States
Retina Associates of Cleveland, Inc
Beachwood, Ohio, United States
Cincinnati Eye Institute
Cincinnati, Ohio, United States
Ohio State University
Columbus, Ohio, United States
Midwest Retina, Inc.
Dublin, Ohio, United States
Retina & Vitreous Center SO, PC
Ashland, Oregon, United States
Oregon Health Sciences University
Portland, Oregon, United States
Pennsylvania Retina Specialists, P.C.
Camp Hill, Pennsylvania, United States
Black Hills Regional Eye Institute
Rapid City, South Dakota, United States
Austin Retina Associates
Austin, Texas, United States
Retina and Vitreous of Texas
Beaumont, Texas, United States
The University of Texas Medical Branch
Galveston, Texas, United States
Premiere Retina Specialists
Midland, Texas, United States
Retina Associates of South Texas, PA
San Antonio, Texas, United States
Strategic Clinical Research Group, LLC
Willow Park, Texas, United States
University of Utah, John Moran Eye Center
Salt Lake City, Utah, United States
Virginia Eye Consultants
Norfolk, Virginia, United States
Wagner Macula and Retina Center
Virginia Beach, Virginia, United States
Vitreoretinal Associates of Washington
Bellevue, Washington, United States
Spokane Eye Clinical Research
Spokane, Washington, United States
West Virginia University Eye Institute
Morgantown, West Virginia, United States
Save Sight Institute, University of Sydney Eye Hospital
Sydney, New South Wales, Australia
Sydney Retina Clinic and Day Surgery
Sydney, New South Wales, Australia
Sydney West Retina
Westmead, New South Wales, Australia
Centre for Eye Research Australia
East Melbourne, Victoria, Australia
Specialist Eye Group
Glen Waverley, Victoria, Australia
Lions Eye Institute
Nedlands, Western Australia, Australia
Centro Brasileiro de Cirurgia de Olhos - CBCO
Goiânia, Goiás, Brazil
Instistuto da Visao - Hospital de Olhos Ltda
Belo Horizonte, Minas Gerais, Brazil
Hospital Oftalmologico de Sorocaba
Sorocaba, São Paulo, Brazil
Clinica de Olhos Dr. Suel Abujamra
São Paulo, , Brazil
Instituto Da Visao UNIFESP EPM (Universidade Federal de Sao Paulo - Escola Paulista de Medicina)
São Paulo, , Brazil
Calgary Retina Consultants
Calgary, Alberta, Canada
St Joseph's Health Care London - Ivey Eye Institute
London, Ontario, Canada
Canadian Centre for Advanced Eye Therapeutics Inc
Mississauga, Ontario, Canada
University of Ottawa Eye Institute
Ottawa, Ontario, Canada
Toronto Retina Institute
Toronto, Ontario, Canada
Rigshospitalet-Glostrup
Glostrup Municipality, Capital Region, Denmark
Odense University Hospital
Odense, Region Syddanmark, Denmark
Magyar Honvedseg Egeszegugyi Kozpont
Budapest, , Hungary
Semmelweis University
Budapest, , Hungary
Bajcsy-Zsilinszky Hospital
Budapest, , Hungary
Szent Imre Teaching Hospital
Budapest, , Hungary
Budapest Retina Associates Kft.
Budapest, , Hungary
University of Debrecen, Medical Center
Debrecen, , Hungary
Ganglion Medical Centre
Pécs, , Hungary
University of Szeged
Szeged, , Hungary
Markusovszki Teaching Hospital
Szombathely, , Hungary
Ospedale Clinicizzato
Chieti, Abruzzo, Italy
Clinica Oculistica, Ospedale Santa Maria della Misericordia
Udine, Friuli Venezia Giulia, Italy
Eye Clinic - Fondazione IRCCS
Milan, Lombardy, Italy
Clinica Oculistica- Dipartimento di Scienze Cliniche Universita di Milano
Milan, Lombardy, Italy
Ospedale Molinette
Turin, Piedmont, Italy
Azienda Ospedaliero-Universitaria Careggi - SOD Oculistica, Dipartimento di Chirurgia e Medicina Traslazionale
Florence, Tuscany, Italy
Azienda Universitaria Ospedaliera Pisana, Ospedale "Nuovo S.Chiara" Cisanello
Pisa, Tuscany, Italy
IRCCS - Istuto di Recovero e Cura a Carattere Scientifico
Verona, Vento, Italy
A.O.U. Policlinico Sant Orsola Malpighi Pad1, 4Piano, Studio Medici via Pelagio Palagi 9
Bologna, , Italy
Clinica Oculistica DINOGMI Universita di Genova
Genova, , Italy
IRCCS Ospedale San Raffaele
Milan, , Italy
Policlinico Agostino Gemelli
Roma, , Italy
Fondazione G.B. Bietti-IRCCS
Roma, , Italy
Aichi Medical University Hospital
Nagakute, Aichi-ken, Japan
Japan Community Health Care Organization Chukyo Hospital
Nagoya, Aichi-ken, Japan
Nagoya University Hospital
Nagoya, Aichi-ken, Japan
Kameda Clinic
Kamogawa, Chiba, Japan
Toho University Sakura Medical Center
Sakura, Chiba, Japan
Juntendo University Urayasu Hospital
Urayasu, Chiba, Japan
Ogaki Tokushukai Hospital
Ōgaki, Gifu, Japan
Kimura Eye And Internal Medicine Hospital
Kure, Hiroshima, Japan
Sapporo City General Hospital
Sapporo, Hokkaido, Japan
Hyogo Prefectural Amagasaki Hospital General Medical Center
Amagasaki, Hyōgo, Japan
Tokyo Medical University Ibaraki Medical Center
Inashiki, Ibaraki, Japan
Mito Kyodo General Hospital
Mito, Ibaraki, Japan
Otakeganka Tsukimino Clinic
Yamato, Kanagawa, Japan
Kikuna Yuda Eye Clinic
Kanagawa, Kanto, Japan
Mie University Hospital
Tsu, Mie-ken, Japan
Iida Municipal Hospital
Iida, Nagano, Japan
Shiga University of Medical Science Hospital
Ōtsu, Shiga, Japan
Seirei Hamamatsu General Hospital
Hamamatsu, Shizuoka, Japan
Nihon University Hospital
Chiyoda City, Tokyo, Japan
Chofu Eye Clinic
Chōfu, Tokyo, Japan
Tokyo Medical University Hachioji Medical Center
Hachiōji, Tokyo, Japan
Takeuchi Eye Clinic
Taitō City, Tokyo, Japan
Kyushu University Hospital
Fukuoka, , Japan
Fukushima Medical University Hospital
Fukushima, , Japan
Kokura Kinen Hospital
Kitakyushu, , Japan
Ideta Eye Hospital
Kumamoto, , Japan
The Japanese Red Cross Nagasaki Genbaku Hospital
Nagasaki, , Japan
Nara Medical University Hospital
Nara, , Japan
Medical Corporation Jinshikai Nishi Eye Hospital
Osaka, , Japan
Musashi Dream Clinic
Osaka, , Japan
Tane Memorial Eye Hospital
Osaka, , Japan
Tokyo Women's Medical University Hospital
Tokyo, , Japan
Elisabeth Hospital
Tilburg, North Brabant, Netherlands
Academic Medical Center
Amsterdam, North Holland, Netherlands
Oogziekenhuis Rotterdam
Rotterdam, North Holland, Netherlands
Leiden University Medical Center
Leiden, South Holland, Netherlands
Macula D&T Eye Center
San Isidro, Lima region, Peru
Optimum Profesorskie Centrum Okulistyki
Gdansk, , Poland
Klinika Okulistyczna Jasne Blonia
Lodz, , Poland
Centrum Diagnostyki i Mikrochirurgii
Olsztyn, , Poland
Retina Eye Hospital
Warsaw, , Poland
Uniwersytecki Szpital Kliniczny
Wroclaw, , Poland
Scientific Research Institute of Ocular Diseases of RAMS
Moscow, , Russia
S. Fyodorov Eye Microsurgery Federal State Institution
Moscow, , Russia
Pasteur Medical Centre
Bloemfontein, , South Africa
Dr Actons Privat Practice
Cape Town, , South Africa
Pretoria Eye Institute, Private Practice
Pretoria, , South Africa
Department of Ophthalmology Kaohsiung Veterans General Hospital
Kaohsiung City, , Taiwan
Kaohsiung Chang Gung Memorial Hospital
Kaohsiung City, , Taiwan
Department of Ophthalmology National Taiwan University Hospital
Taipei, , Taiwan
Shin Kong Wu Ho-Su Memorial Hospital
Taipei, , Taiwan
Chang Gung Medical Foundation, Linkou Branch
Taoyuan District, , Taiwan
Ankara Uni Med Fac
Ankara, , Turkey (Türkiye)
Dokuz Eylul Uni Med Fac
Izmir, , Turkey (Türkiye)
Frimley Park Hospital
Frimley, Camberley, United Kingdom
Royal Derby Hospital
Derby, Derbyshire, United Kingdom
ESNEFT Essex County Hospital
Colchester, Essex, United Kingdom
University Hospital Southampton
Southampton, Hampshire, United Kingdom
Oxford Eye Hospital, John Radcliffe Hospital
Oxford, Headington, United Kingdom
Royal Liverpool University Hospital
Liverpool, North West England, United Kingdom
Royal Surrey Hospital
Guildford, South East, United Kingdom
Heart of England NHS Foundation Trust, Good Hope Hospital
Sutton Coldfield, Staffordshire, United Kingdom
University Hospital of Wales
Cardiff, Wales, United Kingdom
Bradford Royal Infirmary (BRI)
Bradford, West Yorkshire, United Kingdom
Sheffield Teaching Hospitals
Sheffield, Yorkshire, United Kingdom
Barnet Hospital
Barnet, , United Kingdom
Bristol Eye Hospital
Bristol, , United Kingdom
University Hospital Aintree
Liverpool, , United Kingdom
Moorfields Eye Hospital
London, , United Kingdom
Barnet Royal Free Hospital
London, , United Kingdom
King's College Hospital
London, , United Kingdom
Royal Victoria Infirmary
Newcastle, , United Kingdom
Hospital of St. Cross
Rugby, , United Kingdom
City Hospitals Sunderland NHS
Sunderland, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Statistical Analysis Plan
Document Type: Study Protocol
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2014-004580-20
Identifier Type: EUDRACT_NUMBER
Identifier Source: secondary_id
SEQUOIA
Identifier Type: OTHER
Identifier Source: secondary_id
150998-006
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.